C
CARSGEN THERAPEUTICS HOLDINGS LTD
HKEX: 2171 (CARSGEN-B)
Last update: 7 hours ago15.46
-0.44 (-2.77%)
| Previous Close | 15.90 |
| Open | 16.34 |
| Volume | 6,153,500 |
| Avg. Volume (3M) | 2,865,556 |
| Market Cap | 8,464,723,456 |
| Price / Sales | 80.33 |
| Price / Book | 6.98 |
| 52 Weeks Range | |
| Earnings Date | 18 Mar 2025 |
| Operating Margin (TTM) | -1,280.12% |
| Diluted EPS (TTM) | -1.58 |
| Total Debt/Equity (MRQ) | 15.75% |
| Current Ratio (MRQ) | 6.03 |
| Operating Cash Flow (TTM) | -409.69 M |
| Levered Free Cash Flow (TTM) | -393.70 M |
| Return on Assets (TTM) | -23.91% |
| Return on Equity (TTM) | -55.84% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (HK) | Mixed | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | CARSGEN-B | - | - |
AIStockmoo Score
-0.3
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | -0.25 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CARSGEN-B | 8 B | - | - | 6.98 |
| GENSCRIPT BIO | 25 B | - | - | 0.720 |
| LEPU BIO-B | 8 B | - | - | 10.02 |
| OCUMENSION-B | 6 B | - | - | 1.32 |
| JACOBIO-B | 5 B | - | - | 5.53 |
| BIODLINK-B | 3 B | - | 211.50 | 3.52 |
|
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People’s Republic of China and the United States of America. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 37.79% |
| % Held by Institutions | 12.43% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |